[Risk assessment in familial breast cancer].

Orv Hetil

Semmelweis Egyetem, Általános Orvostudományi Kar I. Szülészeti és Nőgyógyászati Klinika Budapest Baross u. 27. 1088.

Published: May 2011

Women with a history of breast cancer are common at centers for cancer genetic risk all over Europe. Given limited health care resources, managing this demand, while achieving good value for money coming from health services, is generally a major challenge. This paper recapitulates and summarizes the available methods of the risk assessment of familial breast cancer. After a systematic review of the literature Gail-model, Claus-model and BOADICEA-model were selected, as well as softwares (LINKAGE software; MENDEL v3.3 software) available in the application of these algorhythms are also summarized. Comparisons were made between the models concerning their advantages and disadvantages. The really reliable methods of risk estimation of familial breast cancer are always based on the analysis of the pedigree structure and allow the estimation of the patient's probability of carrying a susceptibility gene under a particular genetic model, given her family history. For this method the knowledge of BRCA mutation status is absolutely indispensable. The methods of BRCA mutation analysis as well as the main characteristics of the occurrence of BRCA mutation carrier condition are discussed in details.

Download full-text PDF

Source
http://dx.doi.org/10.1556/OH.2011.29110DOI Listing

Publication Analysis

Top Keywords

familial breast
12
breast cancer
12
brca mutation
12
assessment familial
8
methods risk
8
[risk assessment
4
breast
4
breast cancer]
4
cancer] women
4
women history
4

Similar Publications

Background & objectives Cancer is a leading cause of death worldwide and constitutes a public health priority. Delays in diagnosis and treatment of cancer can adversely impact survival, recovery, and cost of treatment. The objective of this study was to estimate the proportion seeking timely care among those having early warning signals for oral, breast or cervical cancer and to explore the facilitators and barriers to early detection.

View Article and Find Full Text PDF

The role of paternal support in breastfeeding outcomes: a meta-analytic review.

Int Breastfeed J

December 2024

Department of Nursing, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, 910 Hengshan Road, Xuhui District, Shanghai, China.

Background: The advantages of breastfeeding for maternal and child health have been widely acknowledged on an international scale. However, there is a paucity of research regarding the effectiveness of paternal support in breastfeeding. This study aimed to systematically review the impact of paternal support interventions on breastfeeding and to contribute additional evidence to inform current breastfeeding practices.

View Article and Find Full Text PDF

Unraveling the protein kinase C/NDRG1 signaling network in breast cancer.

Cell Biosci

December 2024

Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy.

N-myc downstream-regulated gene 1 (NDRG1) is a member of the NDRG family of intracellular proteins and plays a central role in a wide range of biological processes including stress response, differentiation, and metabolism. The overexpression of NDRG1 is an indicator of poor prognosis in various types of cancer. Here, we found that NDRG1 is an independent prognostic marker of poor outcome in breast cancer (BC).

View Article and Find Full Text PDF

Introduction And Importance: Hydatid disease, caused by the Echinococcus parasite, is a significant health concern in endemic regions. While commonly found in the liver and lungs, breast involvement is rare. We present a case of a hydatid cyst in the breast of a 34-year-old woman from Ethiopia, initially suspected to be breast cancer.

View Article and Find Full Text PDF

Background: Most research on HIV-1 viremia and cancer risk is from high-income countries. We evaluated the association between HIV-1 viremia and the risk of various cancer types among people with HIV (PWH) in South Africa.

Methods: We analysed data from the South African HIV Cancer Match study, based on laboratory measurements from the National Health Laboratory Services and cancer records from the National Cancer Registry from 2004-2014.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!